Could Metformin Reduce Cancer Death Risk?

Metformin, one of the most widely prescribed diabetes drugs, may have a new, hidden benefit: reducing the risk of dying from some cancers in postmenopausal women with type 2 diabetes, HealthDay reports.

These findings are from a new study in International Journal of Cancer, which found that for women with type 2 diabetes and cancer who are taking Metformin, the risk of dying from cancer was the same as diabetes-free women with cancer. In women with cancer and diabetes who weren’t taking Metformin, their risk of dying from cancer appeared to be  45% higher.

Read complete story.

You may also like

  • Can Intensive Medical Treatment Reverse Type 2 Diabetes?

    Type 2 diabetes can be reversed with intensive medical treatment using oral medications, insulin and lifestyle therapies, according to a study published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Hertzel C. Gerstein, MD, MSc, FRCPC, of McMaster University and Hamilton Health Sciences in Hamilton, Ontario, Canada randomly divided 83 individuals with…

  • Recent Survey Finds Many Adults with Diabetes Unaware of Their Increased Risk for Certain Serious Illnesses

    Many adults with diabetes are unaware of their increased risk for certain serious illnesses, according to a recent national, online consumer awareness survey sponsored by Merck and the American Diabetes Association, and conducted by Harris Poll. In the survey of 1,003 U.S. adults ages 18 years and older diagnosed with diabetes, respondents were twice as…